Dragoi, A.M.; Radulescu, I.; Năsui, B.A.; Pop, A.L.; Varlas, V.N.; Trifu, S.
Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19. Brain Sci. 2020, 10, 840.
https://doi.org/10.3390/brainsci10110840
AMA Style
Dragoi AM, Radulescu I, Năsui BA, Pop AL, Varlas VN, Trifu S.
Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19. Brain Sciences. 2020; 10(11):840.
https://doi.org/10.3390/brainsci10110840
Chicago/Turabian Style
Dragoi, Ana Miruna, Ioana Radulescu, Bogdana Adriana Năsui, Anca Lucia Pop, Valentin Nicolae Varlas, and Simona Trifu.
2020. "Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19" Brain Sciences 10, no. 11: 840.
https://doi.org/10.3390/brainsci10110840
APA Style
Dragoi, A. M., Radulescu, I., Năsui, B. A., Pop, A. L., Varlas, V. N., & Trifu, S.
(2020). Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19. Brain Sciences, 10(11), 840.
https://doi.org/10.3390/brainsci10110840